Pankreas Kanserli Hastalarýmýzýn Genel Özellikleri ve Saðkalým Sonuçlarý

Fourty-three patients with pancreatic cancer treated at Radiation Oncology Department of Ankara Oncology Hospital between January 2000-December 2005 were revieved retrospectively. Median age of the patients were 56 (betvveen 38 and 78). Male/female ratio was 3.3/1. Adenocarcinoma was the most common histology. Most ofthem were T3 or T4 tumors. Head of the pancreas was the most common site. Twenty-one patients were operated, 22 patients were inoperable. Among inoperabie patients 9 of them were irradiated for curative purpose, 9 were irradiated for paliation. Overall 1, 2, 3 years survival rates were 56%, 34%, 20% respectively and the median survival time was 14 months. Ýn conciusion, pancreatic cancer has a poor prognosis and there is a need for new treatment modalities.

General Features of Pancreatic Cancer Patients and Survival Results

Ankara Onkoloji Hastanesi Radyasyon Onkolojisi Kliniðine 1 Ocak 2000-31 Aralýk 2005 tarihleri arasýnda baþvuran 43 pankreas kanserli hasta retrospektif olarak deðerlendirildi. Hastalar; genel özellikleri ve saðkalým sonuçlan açýsýndan incelendi. Hastalarýn median yaþý 56 (min 38-maks 78 ), erkek/kadýn oraný 3.3/1 olarak bulundu. En sýk rastlanan tümör histopatolojisi adenokarsinom idi. Kliniðimize en çok T3 ve T4 hastalar baþvurmuþtu. Tümör en çok pankreas baþýnda lokalize idi. Kýrk üç hastanýn 21’i öpere, 22’si inopere idi. inopere olanlardan 9’u paiyatif, 9’u küratif amaçla ýþýnlanmýþtý. Tüm grupta 1, 2, 3 yýllýk saðkalýmlar sýrasýyla %56, %34, %20 ve median saðkalým 14 ay olarak bulundu. Pankreas kanserinin tedavisinde yeni tedavi yaklaþýmlarýna gerek olduðu sonucuna ulaþýldý.